To explore the relationship between cefiderocol pharmacokinetic/pharmacodynamic (PK/PD) target attainment and microbiological outcome in critically ill patients affected by extensively drug-resistant Acinetobacter baumannii (XDR-AB) bloodstream infection (BSI) and/or ventilator-associated pneumonia (VAP).

Gatti, M., Bartoletti, M., Cojutti, P.G., Gaibani, P., Conti, M., Giannella, M., et al. (2021). A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 27, 294-298 [10.1016/j.jgar.2021.10.014].

A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol

Gatti, Milo;Bartoletti, Michele;Cojutti, Pier Giorgio;Gaibani, Paolo;Giannella, Maddalena;Viale, Pierluigi;Pea, Federico
2021

Abstract

To explore the relationship between cefiderocol pharmacokinetic/pharmacodynamic (PK/PD) target attainment and microbiological outcome in critically ill patients affected by extensively drug-resistant Acinetobacter baumannii (XDR-AB) bloodstream infection (BSI) and/or ventilator-associated pneumonia (VAP).
2021
Gatti, M., Bartoletti, M., Cojutti, P.G., Gaibani, P., Conti, M., Giannella, M., et al. (2021). A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 27, 294-298 [10.1016/j.jgar.2021.10.014].
Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2213716521002290-main.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 495.06 kB
Formato Adobe PDF
495.06 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/837178
Citazioni
  • ???jsp.display-item.citation.pmc??? 34
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 41
social impact